NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 195 filers reported holding NEVRO CORP in Q3 2016. The put-call ratio across all filers is 1.24 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $16,644,000 | +236.3% | 266,256 | +109.2% | 0.01% | +200.0% |
Q4 2018 | $4,949,000 | -66.2% | 127,255 | -50.5% | 0.00% | -20.0% |
Q3 2018 | $14,656,000 | +186.1% | 257,132 | +300.8% | 0.01% | +66.7% |
Q2 2018 | $5,123,000 | -12.1% | 64,160 | -4.6% | 0.00% | -25.0% |
Q1 2018 | $5,828,000 | -65.5% | 67,242 | -72.5% | 0.00% | -63.6% |
Q4 2017 | $16,874,000 | -25.4% | 244,413 | -1.9% | 0.01% | -26.7% |
Q3 2017 | $22,632,000 | +21.4% | 249,036 | -0.6% | 0.02% | +15.4% |
Q2 2017 | $18,646,000 | +205.6% | 250,514 | +284.7% | 0.01% | +225.0% |
Q1 2017 | $6,101,000 | +20.9% | 65,116 | -6.2% | 0.00% | 0.0% |
Q4 2016 | $5,046,000 | -33.4% | 69,445 | -4.3% | 0.00% | -20.0% |
Q3 2016 | $7,579,000 | +40.1% | 72,601 | -1.0% | 0.01% | +25.0% |
Q2 2016 | $5,410,000 | +92.0% | 73,350 | +46.4% | 0.00% | +100.0% |
Q1 2016 | $2,818,000 | -20.9% | 50,090 | -5.1% | 0.00% | -33.3% |
Q4 2015 | $3,564,000 | +43.1% | 52,796 | -1.6% | 0.00% | +50.0% |
Q3 2015 | $2,490,000 | -22.0% | 53,666 | -9.7% | 0.00% | 0.0% |
Q2 2015 | $3,193,000 | +124.2% | 59,400 | +99.9% | 0.00% | +100.0% |
Q1 2015 | $1,424,000 | +121.1% | 29,719 | +78.4% | 0.00% | – |
Q4 2014 | $644,000 | – | 16,661 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadfin Capital, LLC | 622,615 | $38,920,000 | 8.04% |
Tamarack Advisers, LP | 160,000 | $10,002,000 | 3.97% |
Birch Run Capital Advisors, LP | 187,425 | $11,716,000 | 3.72% |
Prosight Management, LP | 128,765 | $8,049,000 | 3.52% |
Ratan Capital Management LP | 38,653 | $2,416,000 | 3.44% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 579,463 | $36,222,000 | 1.39% |
Spark Investment Management LLC | 403,400 | $25,216,000 | 1.17% |
Sivik Global Healthcare LLC | 50,000 | $3,126,000 | 1.15% |
ArrowMark Colorado Holdings LLC | 1,882,009 | $117,644,000 | 1.11% |
PFM Health Sciences, LP | 721,229 | $45,084,000 | 1.00% |